Navigation Links
Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies
Date:9/10/2009

STOCKHOLM, September 10 /PRNewswire/ -- Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

The Pergamum product pipeline consists of five development projects, three of which are undergoing clinical trials. Indications covered within the portfolio include improved wound healing and reduced scar formation, healing hard-to-heal-wounds, the prevention of bacterial and fungal infections, atopic dermatitis and infected wounds and burns.

Pergamum CEO Magnus Precht will present Pergamum at the Rodman & Renshaw Annual Global Investment Conference in New York September 9-11, 2009 and will be available for one-on-one meetings with investors and potential partners during the conference.

"Pergamum represents a unique approach to developing new biopharmaceuticals in the dermatology and wound care markets," said Magnus Precht, CEO of Pergamum AB. "The fact that the group is working within related fields means we are able to build capabilities and specialist knowledge tailored to the needs of the group. We will provide individual projects with access to technical skills and key competencies without creating bureaucratic layers. This should translate into improved quality, cost savings and, ultimately, a shorter path to regulatory approval. It also means we have a broader, more attractive offering when meeting with pharma companies to discuss eventual sales or licensing opportunities," added Mr Precht.

Pergamum's current projects include: wound healing (Omnio Healer), atopic dermatitis / anti-inflamatory (BioCis Pharma), atopic dermatitis / anti-infective (DermaGen), anti-adhesion / wound healing (PharmaSurgics), and wound healing for chronic wounds (Lipopeptide). Karolinska Development owns 64% of Pergamum, with the other owners being Ostersjostiftelsen (The Foundation for Baltic and East European Studies) and Midroc New Technology.

Karolinska Development's CEO, Conny Bogentoft, said, "We are extremely pleased with this new initiative. By consolidating all of our interests in the dermatology and wound healing field in this way we have created an extremely resource-efficient business model. It should provide both more effective project development and greater efficiency when seeking exit opportunities."

About Karolinska Development:

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development

AB is a new type of company focused on filling the innovation gap within the pharmaceutical industry. Using a unique, highly cost-effective model Karolinska Development commercializes internationally renowned life science innovations, helping to deliver the medical products of the future.

    For more information please contact:

    Magnus Precht, CEO, Pergamum AB
    European mobile phone: +46-73-515-7450
    US cell phone:         +1-817-312-7277
    magnus.precht@pergamum.com
   http://www.pergamum.com

    Conny Bogentoft, CEO, Karolinska Development AB
    Cell phone: +46-70-668-61-43
    info@karolinskadevelopment.com
   http://www.karolinskadevelopment.com


'/>"/>
SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
2. Hyland Software Provides Grant Assistance to Kick-Start Technology Projects
3. PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
4. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
7. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
8. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
9. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
10. ThermoGenesis Provides Update on Fiscal 2009 Results
11. GeoVax Labs, Inc. Provides Clinical Studies Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... BioRap Technologies Ltd , the technology transfer ... Technion - Israel Institute of Technology, has entered into a ... PFE ) that aims to further develop a ... number of chronic autoimmune diseases. The collaboration is ... Karin and his research team, led by Dr. Anunu ...
(Date:5/31/2016)... , ... May 31, 2016 , ... The Academy of ... Museum that will be on display Memorial Day through Labor Day 2016. Bill Chaffee’s ... and Clark Chaffee. , Bill Chaffee won first place for Senior Scale Model ...
(Date:5/27/2016)... ... ... Doctors in Italy, Japan, the UK and the US have reached some surprising ... its link to malignant mesothelioma. Surviving Mesothelioma has just posted the details of their ... , The studies analyzed for the new report included more than 3,447 cancer patients. ...
(Date:5/26/2016)... and READING, England ... Indegene ( http://www.indegene.com ), a leading global provider ... science, pharmaceutical and healthcare organisations and TranScrip ( ... scientific support throughout the product lifecycle, today announced ... launch of IntraScience.      (Logo: ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
Breaking Biology News(10 mins):